Skip to main content
← Back to work

Works cited by this work

248 works

Work: siRNA-based strategies to combat drug resistance in gastric cancer

  1. Clinical Pharmacokinetics of Doxorubicin

    P A Speth, Q.G.C.M. van Hoesel, C. Haanen

    Review article19882 citations
    ABI
  2. Targeting EZH2 in cancer

    Kimberly H. Kim, Charles W.M. Roberts

    Review article20162 citations
    ABI
  3. LncRNA UCA1 in anti-cancer drug resistance

    Haohao Wang, Zhonghai Guan, Kuifeng He +3

    Review article20172 citations
    ABI
  4. Epithelial Mesenchymal Transition in Tumor Metastasis

    Vivek Mittal

    Review article20182 citations
    ABI
  5. Noncoding RNAs in gastric cancer: implications for drug resistance

    Ling Wei, Jujie Sun, Nasha Zhang +7

    Review article20202 citations
    ABI
  6. EZH2: a novel target for cancer treatment

    Ran Duan, Wenfang Du, Weijian Guo

    Review article20202 citations
    ABI
  7. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance

    Xiaolin Wang, Jiahui Zhang, Guozhen Cao +3

    Review article20222 citations
    ABI
  8. CircRNA: A new class of targets for gastric cancer drug resistance therapy

    Ying Zheng, Zhe Li, Yao Wang +4

    Review article20232 citations
    ABI
  9. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

    Qiang Lü, Dongquan Kou, Shenghan Lou +13

    Article20242 citations
    ABI
  10. Untitled

    Other2 citations
    ABI
  11. Untitled

    Other1 citations
    ABI
  12. Untitled

    Other1 citations
    ABI
  13. Untitled

    Other1 citations
    ABI
  14. Untitled

    Other1 citations
    ABI
  15. Untitled

    Other1 citations
    ABI
  16. Untitled

    Other1 citations
    ABI
  17. Untitled

    Other1 citations
    ABI
  18. Untitled

    Other1 citations
    ABI